Short answer
Xencor Inc (XNCR) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $117M (up 454.9% year over year) with net income of $39M.
Q3 2026 key financials · XBRL
- Revenue
- $117M
- +454.9% YoY · +127.5% QoQ
- Net income
- $39M
- +754.3% YoY · +281.5% QoQ
- Operating margin
- 19.6%
- EPS (diluted)
- $0.52
- +750.0% YoY · +285.7% QoQ
Source: XBRL data from the Xencor Inc (XNCR) Q3 2026 10-Q on SEC EDGAR. USD.
Xencor Inc Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $116.5M, up $95.5M YoY, driven by royalty and milestone recognition
- Operating margin 19.6% vs negative 226.3% YoY, with operating income $22.9M vs loss of $47.5M
- Best revenue contributor: Alexion royalties $83.5M vs $18.7M YoY
- R&D expenses $84.3M, up $29.9M YoY, led by XmAb942 external costs of $11.8M
- Cash, equivalents and marketable debt securities $555.7M vs $610.8M at December 31, 2025, with nine-month operating cash flow of negative $120.6M
Risk Factors
- Newly updated legal risk: Merus patent disputes resolved July 2026, including dismissal with prejudice and terminated inter partes reviews
- Financial benefit from settlement: $7.0 million cash payment received from Merus in July 2026
- Intellectual-property risk: Future infringement claims could require royalties, licensing, treble damages, or commercialization cessation
- Operational risk: Patent litigation could divert management time and resources from product development and commercialization
- Carried-forward competitive risk: Larger competitors may sustain complex patent-litigation costs more effectively due to greater resources
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Xencor Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.